Here, we combined both bioinformatic analysis and empirical studies using clinical specimens and cell culture systems to empirically establish a tumor suppressive role of transcriptional repressor E2F7 and to better define an oncogenic role of transcriptional activator E2F1 and their potential target gene MYBL2 in GC. This evidence concerns the gene E2F7 and gastric cancer.